All blog posts
Total 290 results for
Showing 48 out of 290 results
31 July 2025
EU Regulatory Reform for Medicinal Products: Bolar exemption
30 July 2025
When will modifying a chemical scaffold be inventive? The UK Court of Appeal opines in the Xtandi case
21 July 2025
Trends emerging as the UPC enters its third year
03 June 2025
Valuation of FRAND licences in the UK
13 May 2025
EU Regulatory Reform for Medicinal Products: Changes to MAs, supply, and transparency
30 April 2025
EU Regulatory Reform for Medicinal Products: Review of new regulatory exclusivities
07 March 2025
Lenovo v Ericsson – the UK strikes back?
25 February 2025
CJEU clears the way for single courts determining infringement actions in multiple jurisdictions without invalidity counterclaims interfering with the process (BSH Hausgerate v Electrolux)
12 February 2025
European Commission shelves proposed SEP regulation
10 February 2025
Key Takeaways from the UPC Litigation Forum and Pharma & Biotech Patent Litigation Europe Summit 2025
30 January 2025
The UPC at 18 months
29 January 2025
Could we…and would we..? UK CoA confirms that it is bound by previous precedent on second medical use SPCs
Showing 48 out of 290 results
View moreKey contacts
Rebekah Gay
Partner, Head of Intellectual Property, Sydney
Laura Orlando
Managing Partner, Milan Office, Milan
Sue Gilchrist
Consultant, Sydney
Peng Lei
Partner, Herbert Smith Freehills Kramer Kewei Joint Operation, Mainland China and Shanghai
Alexandra Neri
Partner, Paris
Dr Ina vom Feld
Partner, Germany
Sebastian Moore
Partner, Head Intellectual Property, London and Milan
Rachel Montagnon
Knowledge Counsel, London